A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
J01 ANTIBACTERIALS FOR SYSTEMIC USE
|
J02 ANTIMYCOTICS FOR SYSTEMIC USE
|
J04 ANTIMYCOBACTERIALS
|
J05 ANTIVIRALS FOR SYSTEMIC USE
|
J05A DIRECT ACTING ANTIVIRALS
|
J05AA Thiosemicarbazones
|
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
|
J05AC Cyclic amines
|
J05AD Phosphonic acid derivatives
|
J05AE Protease inhibitors [DG:DG01647]
|
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
|
J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
|
J05AH Neuraminidase inhibitors [DG:DG02842]
|
J05AH01 Zanamivir [DG:DG00664]
|
D00902 Zanamivir (USP/INN) <US>
D01937 Zanamivir hydrate (JAN) <JP>
|
J05AH02 Oseltamivir [DG:DG00665]
|
J05AH03 Peramivir
|
J05AH04 Laninamivir [DG:DG01201]
|
J05AJ Integrase inhibitors [DG:DG03135]
|
J05AP Antivirals for treatment of HCV infections
|
J05AR Antivirals for treatment of HIV infections, combinations
|
J05AX Other antivirals
|
J06 IMMUNE SERA AND IMMUNOGLOBULINS
|
J07 VACCINES
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|